Verve Therapeutics (VERV) Stock Highlights

5.74 | +11.24%

2024-12-21 05:22:12

Verve Therapeutics Inc is a genetic medicines company pioneering a new approach to the care of cardiovascular disease, transforming treatment from chronic management to single-course gene editing medicines. The companys initial two programs target PCSK9 and ANGPTL3, genes that have been extensively validated as targets for lowering blood lipids such as low-density lipoprotein cholesterol, a root cause of cardiovascular disease. The company views its operations as and manages its business in one operating segment operating exclusively in the United States.

Statistics

Range Today

5.12 5.76

Volume Today 3.82M

Range 1 Year

4.3 19.34

Volume 1 Year 341.67M

Range 3 Year

4.3 43

Volume 3 Year 797.38M

Range 10 Year

4.3 78

Volume 10 Year 858.17M

Highlights

Market Capitalization 538.46M (small)

Floating Shares 62.44M

Current Price 5.74

Price To Earnings -2.61

Price To Revenue 2.69

Price To Book 1.05

Earnings Per Share -2.44

Payout Ratio 0%

Performance

Latest +11.24%

1 Month +18.6%

3 Months +7.89%

6 Months +13.66%

1 Year -60.22%

3 Years -84.93%

5 Years -80.87%

10 Years -80.87%

Benchmarks

Market Capitalization

103 / 368

Gross Profits

247 / 278

Total Revenue

190 / 300

Total Rank

59 / 368

Free Cashflow

292 / 352

Performance 5 years

232 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.